Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00430482 · ClinicalTrials.gov registry record · NA
Stress, Distress Intolerance, and Drug Dependence
A NA study, sponsored by Boston University Charles River Campus.
- Completed
- Registry status
- NA
- Development phase
- 133
- Enrollment target
NCT00430482 is a NA study that has completed, run by Boston University Charles River Campus. The registered enrollment target is 133 participants.
The verdict
NCT00430482, a NA study, has completed, sponsored by Boston University Charles River Campus.
- COMPLETED
- Registry status
- NA
- Development phase
- 133 participants
- Enrollment target
Study Summary
This study is designed to evaluate the relative efficacy of a novel treatment (CBT-IC) versus a standard individual drug-counseling treatment. The novel treatment emphasizes exposure to emotional cues for drug use as part of a comprehensive, yet brief, treatment strategy. These treatments are delivered to opiate-dependent, often poly-substance dependent, individuals in a comprehensive methadone maintenance program who have failed to respond adequately to current treatments.
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy
- BEHAVIORAL Individual Counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 133 participants |
| Start Date | 2005-06 |
| Est. Completion | 2011-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00430482
The ClinicalTrials.gov registry entry for NCT00430482 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 133 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University Charles River Campus, which has 104 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cognitive Behavioral Therapy is the first listed.
NCT00430482 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00430482 about?
NCT00430482 is a clinical study titled "Stress, Distress Intolerance, and Drug Dependence". This study is designed to evaluate the relative efficacy of a novel treatment (CBT-IC) versus a standard individual drug-counseling treatment. The novel treatment emphasizes exposure to emotional cues for drug use as part of a comprehensive, yet brief, treatment strategy. These treatments are delive...
What is the current status of trial NCT00430482?
This trial is currently completed. It is a NA study. The enrollment target is 133 participants. The study started on 2005-06. Estimated completion is 2011-07.
What interventions are being tested in trial NCT00430482?
The interventions under investigation include: Cognitive Behavioral Therapy (BEHAVIORAL), Individual Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT00430482?
This trial is sponsored by Boston University Charles River Campus, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.